EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma

Marko Tarle iD, Marina Raguž, Danko Muller, Ivica Lukšić iD

International Journal of Molecular Sciences · 18.03.2023 · 24 (6) · 5816

DOI: 10.3390/ijms24065816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2023. Verfasst von Marko Tarle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to determine, by immunohistochemical methods, the expression of nEGFR and markers of cell proliferation (Ki-67), cell cycle (mEGFR, p53, cyclin D1), and tumor stem cells (ABCG2) in 59 pathohistological samples of healthy oral mucosa, 50 oral premalignant changes (leukoplakia and erythroplakia), and 52 oral squamous cell carcinomas (OSCC). An increase in the expression of mEGFR and nEGFR was found with the development of the disease (p < 0.0001). In the group of patients with leukoplakia and erythroplakia, we found a positive correlation between nEGFR and Ki67, p53, cyclin D1, and mEGFR, whereas in the group of patients with OSCC, we found a positive correlation between nEGFR and Ki67, mEGFR (p < 0.05). Tumors without perineural (PNI) invasion had a higher expression of p53 protein than tumors with PNI (p = 0.02). Patients with OSCC and overexpression of nEGFR had shorter overall survival (p = 0.004). The results of this study suggest a potentially important independent role of nEGFR in oral carcinogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellHead and Neck NeoplasmsHumansTumor Suppressor Protein p53Cyclin D1Squamous Cell Carcinoma of Head and NeckKi-67 AntigenLeukoplakiaErbB Receptors

Stichwörter der Autor:innen

biomarkersimmunocytochemistrynEGFRoral cavitysquamous cell carcinoma

Substanzen

Tumor Suppressor Protein p53Cyclin D1Ki-67 AntigenErbB Receptors

Autor:innen und Institutionen

  • Department of Maxillofacial Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia.
  • School of Dental Medicine, University of Zagreb, Gundulićeva 5, 10000 Zagreb, Croatia.
  • Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia.
  • School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia.
  • Department of Pathology and Cytology, Dubrava University Hospital, 10000 Zagreb, Croatia.
  • School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

ORCID-Profile: Marko Tarle, Ivica Lukšić

Zitieren

APA

Tarle, M., Raguž, M., Muller, D., & Lukšić, I. (2023). Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences, 24(6), 5816. https://doi.org/10.3390/ijms24065816

Vancouver

Tarle M, Raguž M, Muller D, Lukšić I. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2023;24(6):5816. doi:10.3390/ijms24065816

BibTeX
@article{Tarle2023,
  author = {Tarle, Marko and Raguž, Marina and Muller, Danko and Lukšić, Ivica},
  title = {Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {5816},
  doi = {10.3390/ijms24065816}
}
Kostenlos starten →